Bluspring Enterprises Ltd
BLUSPRINGBluspring Enterprises Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: Foreign institutions moved −3.1 points over 4 quarters while the operating story went the other way — someone close to the numbers is not convinced.
The price is in a confirmed uptrend (14 weeks in) while the P/E sits at the 53rd percentile of its own 0-year range. Underneath, the last four quarters read improving. What settles it: whether the register turns back in the story’s favour.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Bluspring Enterprises Ltd trades at ₹131, in a confirmed uptrend and 14 weeks into that stage. That is +42.4% against its own 200-day average. It sits at 92% of a 52-week range of ₹46 to ₹139. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 25 straight weeks.
Today the stock is in a confirmed uptrend — week 14 of stage 2, confirmed. At ₹131 it trades +42.4% versus its 200-day average and sits at 92% of its 52-week range (₹46–₹139).
Against the market, two honest reads. Cumulative: over the last 1.2 years the stock moved +72% while the NIFTY 500 moved +0% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 25 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
Bluspring Enterprises Ltd's story is not scored yet against the markers our research file set on 19 July 2026. Where it sits in its own cycle: Not stated in the research file. Our fortnightly research layers last read it on 19 July 2026.
Our read, 19 July 2026. Bluspring is improving operating margin after the demerger and has acquisition-led earnings optionality, but the investment case remains provisional because statutory profit is volatile, reported operating cash is thin, and the announced transactions will need funding and integration proof.
What is proven. Bluspring is improving operating margin after the demerger and has acquisition-led earnings optionality, but the investment case remains provisional because statutory profit is volatile, reported operating cash is thin, and the announced transactions will need funding and integration proof.
What is not proven yet. The thesis improves only if a consolidated result shows operating-margin continuity, higher operating cash without a further extension of payables, and a disclosed acquisition contribution that is not offset by new debt or integration costs. It breaks if operating margin reverses, statutory losses recur from new below-the-line items, or acquisition funding weakens the balance sheet without cash-backed earnings.
🚨 What would change our mind. The thesis improves only if a consolidated result shows operating-margin continuity, higher operating cash without a further extension of payables, and a disclosed acquisition contribution that is not offset by new debt or integration costs. It breaks if operating margin reverses, statutory losses recur from new below-the-line items, or acquisition funding weakens the balance sheet without cash-backed earnings.
Layer 1 read, 19 July 2026 — KEEP. Early post-demerger margin recovery with acquisition optionality, but thin cash and a headline overvaluation on a degraded book-based number. Operating margin recovered from a 0.6% trough to 2.9% and STEAG/LSG acquisitions add forward EBITDA optionality, but FY26 was still a statutory loss and operating cash was only 5 Cr against a -23 Cr net loss. The EXTREME -54% MoS sits on a FALLBACK_BOOK valuation with no normalized earnings, so I discount it and rest the low-conviction hold on the thin-but-improving operating trajectory instead.
What would change Layer 1’s mind. A consolidated result showing operating-margin continuity WITH visibly positive operating cash (not funded by extending payables) and a disclosed acquisition contribution not offset by new debt (its own falsification, sharpened) — that would turn the provisional recovery into a cash-backed P1; a margin reversal, recurring below-the-line losses, or debt-funded integration breaks it toward DROP.
Layer 2 read, 19 July 2026 — BENCH. Early margin recovery is real, but the forward case is acquisition optionality that proven models flag as an inorganic-growth mirage — BENCH. Operating margin is genuinely climbing off a 0.6% trough to ~2.8%, but FY26 was still a net loss (PAT -Rs23cr) with only Rs5cr of operating cash, and the whole forward case rests on two unclosed acquisitions. Two PROVEN fund mental models — 'The Inorganic Growth Mirage' and 'Inorganic Growth as the Default Thesis' — weigh directly against an acquisition-led thesis in a diversified pass-through structure, and the (stale) Diversified sector read calls it a 'deep value mirage... uninvestable for serious capital.' The extreme -54% MoS is a FALLBACK_BOOK artifact and inadmissible, so it neither drops nor saves it; the honest call is BENCH until a consolidated, cash-backed result appears.
What would change Layer 2’s mind. A CONSOLIDATED result showing (a) operating-margin continuity, (b) higher operating cash WITHOUT a further payables extension, and (c) a disclosed acquisition contribution NOT offset by new debt or integration costs [consuming thesis.would_change_my_mind + drivers.acquisition stops_working_if] — that flips BENCH to ADVANCE. A Tier-1 governance/funding red flag on STEAG/LSG closing flips it to DROP.
The test written in advance. Cash conversion remains unproven — Cash conversion remains unproven Operating cash remains low or turns negative as acquisition payments and integration costs appear. by the next result.
The test written in advance. Debt-funded integration — Debt-funded integration Borrowings rise while cash conversion and acquired operating contribution lag management's stated path. by the next result.
What the company does. The recent operating-margin sequence improved from its post-demerger trough, and the latest quarter returned to a small reported profit. That recovery does not yet make statutory earnings a reliable run-rate because previous losses were dominated by below-the-line charges. Management's organic growth, margin and acquisition plans are specific, but their delivery must be assessed through consolidated cash-backed results rather than targets.
| Dial | Now | Was | Why it matters | Watch line |
|---|---|---|---|---|
| Post-demerger operating-margin recovery | in play | — | The latest operating-margin sequence suggests recovery from the post-demerger trough. | Operating margin falls while revenue is stable, or the increase in operating profit fails to translate into operating cash. |
| Acquisition-led mix change | in play | — | The proposed acquisitions can lift group mix if they close, consolidate and convert into cash-backed operating contribution. | Closing, customer retention, integration or debt funding differs materially from management's stated plan. |
| Foundit loss reduction | in play | — | A break-even outcome would remove a recurring drag on the consolidated earnings bridge. | Losses do not narrow in reported results or the target moves later again. |
🚨 What the surface reading misses. The surface reading is: The annual statutory loss suggests that the business has not reached profitability. The research reads it further: Operating profit was positive while other income was negative, so the statutory loss is not equivalent to an operating loss.
🚨 What the surface reading misses. The surface reading is: The rising operating-margin sequence signals improving execution. The research reads it further: Operating profit rose with the margin, which supports a real operating recovery, but the annual operating-profit result remains below the prior year and cash conversion has not yet confirmed the recovery.
Lever 8 · Demerger or value unlock — BUILDING. The latest operating-margin sequence suggests recovery from the post-demerger trough. What proves it keeps working: Post-demerger operating-margin recovery. It stops working if Operating margin falls while revenue is stable, or the increase in operating profit fails to translate into operating cash.
Lever 2 · Value-added mix — BUILDING. The proposed acquisitions can lift group mix if they close, consolidate and convert into cash-backed operating contribution. What proves it keeps working: Acquisition-led mix change. It stops working if Closing, customer retention, integration or debt funding differs materially from management's stated plan.
Sources: our stock research file (19 July 2026) · quarterly results through Jun 26 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Bluspring Enterprises Ltd reported ₹949 Cr of revenue in the Jun 26 quarter, +19.1% year on year. That is the 4th straight quarter of year-on-year growth. Over 2 years it has compounded at 12.3% a year. The last full year, FY26, came in at ₹3,382 Cr. The last four reported quarters add to ₹3,534 Cr.
FY26 revenue came in at ₹3,382 Cr (−2.9% on the year), capping 2 years at 12.3% compound. The latest quarter (Jun 26) printed ₹949 Cr, +19.1% year on year — the 4th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +11.8% growth against the decade's 12.3% — the current year is running in line with its own long-run rate.
FY26-Q4. revenue ₹865 Cr and profit ₹4 Cr as reported.
FY27-Q1. revenue ₹949 Cr and profit ₹-2 Cr as reported.
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Bluspring Enterprises Ltd's operating margin is 2.2% in the Jun 26 quarter, +0.7 percentage points against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged 1.6% to 3.0%. The current quarter sits inside that band.
Why this happened. The comparison is supported by higher quarterly operating profit and a return to a small reported profit. The driver is not complete until the improvement continues without a new below-the-line charge or weaker annual operating cash.
The latest quarter's operating margin is 2.2%, +0.7 pp against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged 1.6%–3.0%.
Why the margin moved: operating margin went +0.7 pp year on year while gross margin went +0.5 pp — the gain came mostly from the gross line: input costs and pricing.
FY26-Q4. revenue ₹865 Cr and profit ₹4 Cr as reported.
FY27-Q1. revenue ₹949 Cr and profit ₹-2 Cr as reported.
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Bluspring Enterprises Ltd posted a net loss of ₹1.6 Cr in the Jun 26 quarter. The full FY26 year was a loss of ₹23.0 Cr. That loss is 0.2% of the quarter's revenue. The same quarter a year earlier lost ₹7.2 Cr. 5 of the last 8 reported quarters were loss-making.
Jun 26 profit was ₹−1.6 Cr, null year on year. On the full year, FY26 printed ₹−23.0 Cr (null).
FY26-Q4. revenue ₹865 Cr and profit ₹4 Cr as reported.
FY27-Q1. revenue ₹949 Cr and profit ₹-2 Cr as reported.
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Bluspring Enterprises Ltd's cash-flow history is too thin to judge how much reported profit converts into cash. In FY26 that was ₹52.0 Cr of operating cash against ₹−23.0 Cr of profit. After ₹58.0 Cr of capital spending, ₹−6.0 Cr was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
Why this happened. Management has described both transactions and their prospective revenue and EBITDA contribution. The base case does not credit these figures until the first consolidated results disclose contribution, costs and funding.
FY26: operating cash of ₹52.0 Cr against reported profit of ₹−23.0 Cr, leaving free cash of ₹−6.0 Cr after ₹58.0 Cr of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Bluspring Enterprises Ltd's cash conversion cycle runs 95 days in FY26, up from 47 days in FY24. Capital spending ran ₹115 Cr over the last 2 years. At FY26 sales of ₹3,382 Cr each day of that cycle holds about ₹9.3 Cr, so roughly ₹880 Cr sits inside the business at any moment.
FY26: debtors at 95 days, inventory at 10 days — roughly 0.3 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 95 days, looser than FY24's 47.
The full loop: cash goes out to suppliers and production on day 0; stock waits 10 days to sell; customers pay about 95 days after that; and suppliers themselves are paid at 177 days — netting out to the 95-day cycle.
In money terms: at FY26 sales of ₹3,382 Cr, each day of the cycle holds about ₹9.3 Cr — so the 95-day loop keeps roughly ₹880 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹115 Cr over the last 2 fiscal years against ₹97.0 Cr of depreciation — building somewhat ahead of wear-and-tear. Capital work-in-progress stands at ₹8.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Bluspring Enterprises Ltd earns a ROCE of 5% in FY26. Return on invested capital clears the cost of that capital by −9.3 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −0.7% net margin on 2.01× asset turns.
FY26 ROCE is 5%.
🚨 Why the return is what it is — the wiring (FY26): −0.7% net margin × 2.01× asset turns × 2.52× balance-sheet leverage ≈ −3.5% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 2.7% − 12.0% = a −9.3 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Bluspring Enterprises Ltd carries total debt of ₹136 Cr against shareholder equity of ₹740 Cr as of Mar 26, a debt-to-equity of 0.18 — effectively unlevered. On the annual view that ratio went from 0.18 in FY25 to 0.18 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹136 Cr against shareholder equity of ₹740 Cr — a debt-to-equity of 0.18. On the annual view, debt-to-equity went from 0.18 (FY25) to 0.18 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions cut 3.1 points of Bluspring Enterprises Ltd over 4 quarters, the biggest move on the register. That takes foreign institutions to 5.7% of the company. Promoters moved −0.2 points over the same window, to 58.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −3.1 points over 4 quarters to 5.7%; Promoters: −0.2 points over 4 quarters to 58.0%; Domestic institutions: +0.2 points over 4 quarters to 8.6%.
🚨 Why the register moved: foreign institutions drove it (−3.1 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Bluspring Enterprises Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Bluspring Enterprises Ltd trades at 130.0× P/E, mid-range by its own standards (53rd percentile). Its long-run median P/E is 125.7×, measured across 0.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 130.0× is mid-range by its own standards (53rd percentile), against a long-run median of 125.7× measured over 0.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Bluspring Enterprises Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 4 quarters across 0 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −2.9% | — | — | — |
| Share price | +66.2% | — | — | — |
4-Factor Sector Score
44.0/100 — rank 10 of 20 in Diversified · 57% evidence confidence
Bluspring Enterprises Ltd scores 44.0 out of 100 against the 20 companies it is compared with in Diversified, ranking 10. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 18.8 + 4.2 + 8.7 + 12.3 = 44. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Said versus delivered
What Bluspring Enterprises Ltd's management promised, set against what actually arrived — 4 tracked promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.
🚨 LSG Acquisition Timeline Slipped · 1 August 2026. In May 2026, management expected to close the LSG acquisition within 30 to 45 days. In August 2026, the transaction was still pending and management again targeted closing in the next couple of weeks, indicating a material delay beyond the prior timetable without a disclosed explanation.
STEAG Asset Scale Recast · 1 August 2026. The May 2026 call described STEAG as managing approximately 7 gigawatts of power assets, while the August 2026 call described its current portfolio as 14-16 gigawatts, roughly a doubling in reported operating scale. Although the latest call refers to four newly won contracts, management did not reconcile whether the higher figure reflects newly mobilized assets, contracted capacity, or a different scope, leaving a material inconsistency in the scale and market-position narrative.
🚨 Q4 FY26 Revenue Growth Guidance Miss · 20 May 2026. In Feb 2026, management stated their focus for Q4 would be on sustaining healthy double-digit revenue growth alongside 4% EBITDA margin guidance. However, Q4 FY26 actual revenue growth came in at 8% year-on-year, significantly falling short of the double-digit guidance that had been signaled with confidence. No explanation was provided in the May 2026 call for this material shortfall against the prior quarter's explicit guidance.
Foundit Break-Even Timeline Extended by 6 Months · 20 May 2026. In Feb 2026, management expressed confidence that Foundit would achieve EBITDA break-even in another three quarters (targeting September 2026 end), with quantified cumulative investment of 30-35 crores post which P&L would turn positive. However, in May 2026, management revised this timeline to end of the financial year (March 31, 2027), effectively pushing back break-even target by 6 months, while Q4 FY26 results showed Foundit still had 9 crores in EBITDA losses, indicating the prior trajectory has significantly slowed.
Every quote above is taken word for word from the company’s own earnings calls.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Sobhagya Mercantile Ltd512014 | 62.8/100Mixed-positive evidence75% evidence | BREAKING OUT | 15.9/35 Revenue 21.9% · PAT 8.1% · OPM change -0.5 pp 95% evidence | 19.1/25 ROCE 23.4% · OPM 14.4% 76% evidence | 9.3/20 P/E 70.7× · PEG — 15% evidence | 18.5/20 RS sector 45.9% · RS bench 52.9% · 1Y 54.3%6 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 19.1 + 9.3 + 18.5 = 62.8 · Decision use: Price leads the evidence: RS versus the benchmark is 52.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 2Kalind Ltd526935 | 60.5/100Mixed-positive evidence82% evidence | 30.6/35 Revenue 100% · PAT 100% · OPM change 21 pp 95% evidence | 18.2/25 ROCE 32% · OPM 63% 76% evidence | 11.1/20 P/E 13.9× · PEG — 50% evidence | 0.6/20 RS sector -89.7% · RS bench -36.7% · 1Y -77%0 of 8 weeks ahead to 2026-08-16 100% evidence | |
| Exact sum: 30.6 + 18.2 + 11.1 + 0.6 = 60.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -89.7% and the one-year return is -77%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Grasim Industries LtdGRASIM | 60.0/100Mixed-positive evidence82% evidence | LEADER | 24.3/35 Revenue 19.5% · PAT 33.1% · OPM change 1 pp 95% evidence | 13.1/25 ROCE 8% · OPM 23% 76% evidence | 6.8/20 P/E 38.9× · PEG — 50% evidence | 15.8/20 RS sector 8.6% · RS bench 14% · 1Y 17%10 of 12 weeks ahead 100% evidence |
| Exact sum: 24.3 + 13.1 + 6.8 + 15.8 = 60 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4BCL Industries LtdBCLIND | 57.1/100Mixed-positive evidence87% evidence | ASLEEP | 20.1/35 Revenue -13.1% · PAT 15.2% · OPM change 3 pp 95% evidence | 14.9/25 ROCE 13.9% · OPM 10% 95% evidence | 13.1/20 P/E 8.7× · PEG — 50% evidence | 9.0/20 RS sector -2.8% · RS bench 2% · 1Y -15.6%5 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 14.9 + 13.1 + 9 = 57.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Indiabulls LimitedIBULLSLTD | 56.0/100Mixed-positive evidence67% evidence | LEADER | 18.4/35 Revenue 100% · PAT 100% · OPM change 28 pp 71% evidence | 14.1/25 ROCE 16.2% · OPM 43% 76% evidence | 10.6/20 P/E 12.6× · PEG — 15% evidence | 12.9/20 RS sector 33.2% · RS bench 38.6% · 1Y 34.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 14.1 + 10.6 + 12.9 = 56 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Balmer Lawrie & Company LtdBALMLAWRIE | 54.3/100Mixed-positive evidence82% evidence | BASING | 17.1/35 Revenue 8.9% · PAT 3.8% · OPM change 1 pp 95% evidence | 15.1/25 ROCE 14.6% · OPM 13% 76% evidence | 14.5/20 P/E 10.3× · PEG — 50% evidence | 7.6/20 RS sector -10.7% · RS bench -6.1% · 1Y -25.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 15.1 + 14.5 + 7.6 = 54.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Nurture Well Industries Ltd531889 | 52.6/100Mixed-positive evidence75% evidence | TURNING | 19.8/35 Revenue 34% · PAT 27% · OPM change 1 pp 95% evidence | 16.5/25 ROCE 22.9% · OPM 11% 76% evidence | 11.5/20 P/E 8.4× · PEG — 15% evidence | 4.8/20 RS sector -33.6% · RS bench -29.8% · 1Y 14.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 16.5 + 11.5 + 4.8 = 52.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Texmaco Infrastructure & Holdings LtdTEXINFRA | 51.9/100Mixed-positive evidence80% evidence | LEADER | 18.9/35 Revenue 5.5% · PAT 100% · OPM change -37.9 pp 95% evidence | 7.4/25 ROCE 1.4% · OPM -48.8% 95% evidence | 8.5/20 P/E 162× · PEG — 15% evidence | 17.1/20 RS sector 10% · RS bench 15.5% · 1Y 22.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 18.9 + 7.4 + 8.5 + 17.1 = 51.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 93M India Ltd3MINDIA | 51.2/100Mixed-positive evidence94% evidence | FADING | 21.9/35 Revenue 15.7% · PAT 16.1% · OPM change -3 pp 100% evidence | 18.7/25 ROCE 50% · OPM 17% 100% evidence | 1.8/20 P/E 83.6× · PEG 3.29 100% evidence | 8.8/20 RS sector -3.7% · RS bench -0.7% · 1Y 7.7%4 of 10 weeks ahead 70% evidence |
| Exact sum: 21.9 + 18.7 + 1.8 + 8.8 = 51.2 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 10Bluspring Enterprises Ltdthis pageBLUSPRING | 44.0/100Thin evidence · provisional57% evidence | BREAKING OUT | 18.8/35 Revenue 11.8% · PAT 90.6% · OPM change 0.7 pp 71% evidence | 4.2/25 ROCE 5.2% · OPM 2.2% 95% evidence | 8.7/20 P/E 130× · PEG — 15% evidence | 12.3/20 RS sector — · RS bench 65.6% · 1Y 63.2%10 of 10 weeks ahead 25% evidence |
| Exact sum: 18.8 + 4.2 + 8.7 + 12.3 = 44 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Nava LtdNAVA | 42.4/100Mixed-negative evidence93% evidence | BASING | 10.0/35 Revenue 9% · PAT -29.9% · OPM change -6 pp 100% evidence | 13.1/25 ROCE 12.8% · OPM 43% 100% evidence | 12.9/20 P/E 20.6× · PEG 1.16 65% evidence | 6.4/20 RS sector -9.8% · RS bench -5.3% · 1Y -18.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 10 + 13.1 + 12.9 + 6.4 = 42.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Tube Investments of India LtdTIINDIA | 37.5/100Mixed-negative evidence100% evidence | ASLEEP | 15.6/35 Revenue 17.6% · PAT 6.6% · OPM change -1 pp 100% evidence | 15.4/25 ROCE 17.1% · OPM 9% 100% evidence | 3.0/20 P/E 80.5× · PEG 9.63 100% evidence | 3.5/20 RS sector -10.7% · RS bench -6.2% · 1Y -12.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 15.4 + 3 + 3.5 = 37.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Bharat Global Developers LtdBGDL | 37.4/100Mixed-negative evidence63% evidence | 8.2/35 Revenue -80% · PAT -80% · OPM change 4.2 pp 95% evidence | 7.2/25 ROCE 0% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.0/20 RS sector 165.8% · RS bench -36.8% · 1Y -47.4%0 of 12 weeks ahead 70% evidence | |
| Exact sum: 8.2 + 7.2 + 10 + 12 = 37.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Andrew Yule & Company LtdANDREWYU | 36.1/100Mixed-negative evidence66% evidence | TURNING | 14.9/35 Revenue -4.8% · PAT -80% · OPM change 25.9 pp 95% evidence | 3.7/25 ROCE -6.3% · OPM -23.4% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 7.5/20 RS sector -37% · RS bench 9.7% · 1Y -1.1%6 of 11 weeks ahead 70% evidence |
| Exact sum: 14.9 + 3.7 + 10 + 7.5 = 36.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Kesar Enterprises LtdKESAR | 35.0/100Thin evidence · provisional51% evidence | 14.4/35 Revenue -9% · PAT 34.7% · OPM change -22132 pp 62% evidence | 4.9/25 ROCE -19.5% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.7/20 RS sector -44.4% · RS bench 0% · 1Y -39.1%0 of 12 weeks ahead 70% evidence | |
| Exact sum: 14.4 + 4.9 + 10 + 5.7 = 35 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Swan Corp LtdSWANCORP | 29.0/100Adverse evidence69% evidence | BASING | 8.7/35 Revenue -16.7% · PAT -67.2% · OPM change -2.6 pp 95% evidence | 5.7/25 ROCE -0.6% · OPM -0.4% 76% evidence | 9.8/20 P/E 41.6× · PEG — 15% evidence | 4.8/20 RS sector -29.3% · RS bench -20.1% · 1Y -34.9%0 of 10 weeks ahead 70% evidence |
| Exact sum: 8.7 + 5.7 + 9.8 + 4.8 = 29 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Integrated Industries LtdIIL | 63.8/100Thin evidence · provisional50% evidence | 20.5/35 Revenue 60.5% · PAT 94.6% · OPM change 2 pp 53% evidence | 16.4/25 ROCE 30.5% · OPM 11% 57% evidence | 10.9/20 P/E 11.6× · PEG — 15% evidence | 16.0/20 RS sector 51.9% · RS bench 63.7% · 1Y 136.8%11 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 20.5 + 16.4 + 10.9 + 16 = 63.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Arunis Abode LtdARUNIS | 50.8/100Thin evidence · provisional45% evidence | 15.2/35 Revenue 100% · PAT 100% · OPM change -17.7 pp 40% evidence | 9.5/25 ROCE -5.3% · OPM 28.5% 57% evidence | 9.4/20 P/E 62.5× · PEG — 15% evidence | 16.7/20 RS sector 131.3% · RS bench 136.7% · 1Y 224%12 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 15.2 + 9.5 + 9.4 + 16.7 = 50.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Piramal Enterprises Ltd(Merged)PEL | 45.1/100Thin evidence · provisional41% evidence | 16.7/35 Revenue -35.5% · PAT 100% · OPM change -9.8 pp 27% evidence | 11.1/25 ROCE 4.9% · OPM 77.4% 57% evidence | 9.6/20 P/E 61.4× · PEG — 15% evidence | 7.7/20 RS sector -20.3% · RS bench 1% · 1Y 3.7%6 of 12 weeks ahead to 2025-09-24 70% evidence | |
| Exact sum: 16.7 + 11.1 + 9.6 + 7.7 = 45.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Rossell India LtdROSSELLIND | 42.6/100Thin evidence · provisional47% evidence | 14.8/35 Revenue 4.8% · PAT -41.1% · OPM change 0.1 pp 36% evidence | 11.7/25 ROCE 6.4% · OPM 10.7% 71% evidence | 10.8/20 P/E 11.8× · PEG — 15% evidence | 5.3/20 RS sector -28.8% · RS bench -19.6% · 1Y -32%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 14.8 + 11.7 + 10.8 + 5.3 = 42.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Bluspring Enterprises Ltd's share price today?
Bluspring Enterprises Ltd trades at ₹131, +66.2% over the past year. The company is valued at ₹1,966 Cr. The stock sits at 92% of its 52-week range of ₹46–₹139, +42.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 14 weeks in. — as of 11 September 2026.
What were Bluspring Enterprises Ltd's latest quarterly results?
Bluspring Enterprises Ltd reported revenue of ₹949 Cr and a net loss of ₹1.6 Cr for the Jun 26 quarter. Earnings per share were ₹−0.03. The operating margin was 2.2%, 0.7 pp higher than a year earlier. — as of 11 September 2026.
What is Bluspring Enterprises Ltd's revenue?
Bluspring Enterprises Ltd reported revenue of ₹949 Cr in the Jun 26 quarter, +19.1% year on year. For the full FY26 fiscal year, revenue was ₹3,382 Cr (−2.9%). Over the last 2 years revenue compounded at 12.3% a year. — as of 11 September 2026.
What is Bluspring Enterprises Ltd's profit?
Bluspring Enterprises Ltd earned ₹−1.6 Cr of net profit in the Jun 26 quarter. Full-year FY26 profit was ₹−23.0 Cr. The operating margin ran 2.2% in the latest quarter. — as of 11 September 2026.
What is Bluspring Enterprises Ltd's market cap?
Bluspring Enterprises Ltd's market capitalisation is ₹1,966 Cr at a share price of ₹131. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Bluspring Enterprises Ltd's P/E ratio?
Bluspring Enterprises Ltd trades at a P/E of 130.0×, at the 53rd percentile of its own 0-year range, against a long-run median of 125.7×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Bluspring Enterprises Ltd pay a dividend?
No — Bluspring Enterprises Ltd has recorded a dividend payout of 0% of profit in each of its last 4 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 11 September 2026.
Is Bluspring Enterprises Ltd overvalued?
On its own history, Bluspring Enterprises Ltd looks mid-range: its P/E of 130.0× sits at the 53rd percentile of its 0-year range (long-run median 125.7×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
How is Bluspring Enterprises Ltd performing?
Bluspring Enterprises Ltd is in a confirmed uptrend, 14 weeks in. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 25 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
Is Bluspring Enterprises Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 14 of stage 2), trading +42.4% versus its 200-day average and at 92% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Bluspring Enterprises Ltd beating the market?
On recent form, yes — Bluspring Enterprises Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 25 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.2 years the stock moved +72% against the NIFTY 500's +0% — ahead of the index over the full window. — as of 11 September 2026.
Will Bluspring Enterprises Ltd's share price go up?
This page publishes no price forecast for Bluspring Enterprises Ltd. What it measures instead: the share price is ₹131, the price is in a confirmed uptrend 14 weeks in. Its P/E of 130.0× sits at the 53rd percentile of its own 0-year range. — as of 11 September 2026.
Who owns Bluspring Enterprises Ltd?
Promoters hold 58.0% of Bluspring Enterprises Ltd, foreign institutions 5.7%, domestic institutions 8.6% and the public 27.6% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 3.1 points over 4 quarters. — as of 11 September 2026.
Does Bluspring Enterprises Ltd have too much debt?
No — Bluspring Enterprises Ltd's debt-to-equity is 0.20, and operating profit covers the interest bill 2×. FY26 borrowings were ₹136 Cr against equity of ₹668 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.
What is Bluspring Enterprises Ltd's capex?
Bluspring Enterprises Ltd spent ₹115 Cr on capital expenditure over the last 2 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹58.0 Cr, with ₹8.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Bluspring Enterprises Ltd's cash flow?
Bluspring Enterprises Ltd generated ₹52.0 Cr of operating cash flow in FY26 and ₹−6.0 Cr of free cash flow after ₹58.0 Cr of capital spending. Reported profit that year was ₹−23.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Where is Bluspring Enterprises Ltd in its business cycle?
Bluspring Enterprises Ltd's FY26 operating margin was 1.6%, against a 4-year band of 1.6%–3.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 2.2%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What could break the Bluspring Enterprises Ltd story?
The sharpest disagreement: Foreign institutions moved −3.1 points over 4 quarters while the operating story went the other way — someone close to the numbers is not convinced. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Bluspring Enterprises Ltd a stock worth studying right now?
This is not investment advice. The machine read: Bluspring Enterprises Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the register turns back in the story’s favour. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!